Patents by Inventor Ferenc BERTHA

Ferenc BERTHA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
    Patent number: 9926332
    Abstract: Compounds of formula (I) having a selective dual action on the central GABAergic system, and a process for their preparation and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: March 27, 2018
    Assignee: Egis Gyogyszergyar Zrt.
    Inventors: Agnes Kenez, Ferenc Bertha, Jozsef Barkoczy, Ferenc Antoni, Istvan Gacsalyi, Balazs Mihalik, Gabor Gigler, Krisztina Moricz, Gabor Nemeth, Agnes Angyalne Pataki, Gabor Laszlo Kapus, Adrienn Palvolgyi, Istvan Ling, Janos Petho, Gyula Simig, Balazs Volk, Lax Gyorgyi Kovanyine, Andras Dancso
  • NEW DIHYDRO-OXAZINOBENZODIAZEPINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITONS CONTAINING THEM
    Publication number: 20170002020
    Abstract: Compounds of formula (I) having a selective dual action on the central GABAergic system, and a process for their preparation and to pharmaceutical compositions containing them.
    Type: Application
    Filed: January 20, 2015
    Publication date: January 5, 2017
    Applicant: Egis Gyogyszergyar Zrt.
    Inventors: Agnes KENEZ, Ferenc BERTHA, Jozsef BARKOCZY, Ferenc ANTONI, Istvan GACSALYI, Balazs MIHALIK, Gabor GIGLER, Krisztina MORICZ, Gabor NEMETH, Agnes ANGYALNE PATAKI, Gabor Laszlo KAPUS, Adrienn PALVOLGYI, Istvan LING, Janos PETHO, Gyula SIMIG, Balazs VOLK, Lax Gyorgyi KOVANYINE, Andras DANCSO
  • 2,3,4-BENZOTHIADIAZEPINE-2,2-DIOXIDE DERIVATIVES
    Publication number: 20120252784
    Abstract: Novel 2,3,4-benzothiadiazepines-2,2-dioxides and processes for the preparation thereof are disclosed. The compounds influence the central nervous system and may be used to treat or prevent Alzheimer's disease, Parkinson's disease or Huntington's disease, senile dementia not of the Alzheimer's type, vascular dementia, post-stroke dementia, Korsakoff's syndrome, Down's syndrome, schizophrenia, panic disorder, post-traumatic stress disorder, anxiety or depression.
    Type: Application
    Filed: March 13, 2012
    Publication date: October 4, 2012
    Inventors: Jozsef FETTER, Ferenc BERTHA, Balazs MOLNAR, Gyula SIMIG, Jozsef BARKOCZY, Balazs VOLK, Gyoergy LEVAY, Istvan GACSALYI, Gabor GIGLER, Hajnalka KOMPAGNE, Bernadett MARKO, Katalin NAGY, Peter KIRICSI, Laszlo Gabor HARSING, Gabor SZENASI